海关远程查检推动湖北生物医药产业加速发展

Core Viewpoint - The implementation of remote inspection by Wuchang Customs is accelerating the development of the biopharmaceutical industry in Hubei, enhancing efficiency in the export of special biological products. Group 1: Remote Inspection Benefits - Wuchang Customs conducted remote inspections via video for a batch of C-level special items, completing the process in just 20 minutes before exporting to Russia [1] - The Wuhan East Lake High-tech Development Zone, a national biopharmaceutical industry base, houses over 400 biopharmaceutical companies, with an average annual export value of special biological products reaching 508 million yuan [1] - The remote inspection model significantly reduces delivery times, with companies reporting an average reduction of 2 days per batch due to the elimination of on-site inspections [1] Group 2: Regulatory Improvements - Wuchang Customs has implemented a classification and grading management system based on enterprise credit and risk assessment for special items in pharmaceutical research, creating a "green channel" for cross-border research collaboration [2] - For imported medical devices and raw materials for research, customs has introduced measures such as "advance declaration" and "inspection upon arrival," which help lower operational costs and financial pressures for enterprises [2] Group 3: Export Statistics - From January to October 2025, Wuchang Customs supervised 3,888 batches of special items for export, with a total value of 349 million yuan [3]